focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.70 (3.846%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 45.05
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Long Term Incentive Plan and PDMR Dealing

12 Dec 2023 17:50

RNS Number : 5506W
Benchmark Holdings PLC
12 December 2023

12 December 2023

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

New Long Term Incentive Plan and PDMR Dealing

Benchmark, the aquaculture biotechnology company, today announces that the Board of Directors has agreed to establish and adopt the Benchmark Holdings Plc Long Term Incentive Plan ("New LTIP") for the senior management team following the expiry of the Company's previous LTIP at the end of its 10-year life.

The Non-Executive Directors have consulted with certain major shareholders of the Group on the New LTIP with a view to creating a simple incentive plan that aligns the potential rewards with shareholder returns and acts as an attractive scheme to retain the senior management team and incentivise shareholder value creation.

Under the terms of the New LTIP, each recipient receiving the awards made on 12 December 2023 was granted both a Restricted Shares award and Performance Shares award over ordinary shares of 0.1p each. The awards granted to PDMRs of the Company were as follows:

Director

No. of shares over which awards granted

Trond Williksen (CEO)

Restricted Shares: 1,825,420

Performance Shares: 1,216,940

Septima Maguire (CFO)

Restricted Shares: 1,244,230

Performance Shares: 829,490

The awards will ordinarily vest and become exercisable at an exercise price of 0.1p per share two years after grant subject to continued service and, for the Performance Shares, to the extent performance conditions are achieved. Participants who leave employment before vesting will lose their award, subject to certain limited 'good leaver' conditions.

Performance conditions for the Performance Shares awards

The Performance Shares awards conditions set threshold to stretch targets in respect of the Company's total shareholder return ("TSR") over the two-year period following the grant of the awards. No portion of the Performance Shares awards shall vest unless the Company's TSR over the performance period reaches the threshold target.

Absolute TSR Growth

Vesting of performance shares

Below 188%1

0%

At 188%

20%

Between 188% and 269%2

20% - 100% on a straight-line basis

At 269% or above

100%

[1] Equivalent to an end share price of 70p from a three-month average base position of 37.17p

2 Equivalent to an end share price of 100p from a three-month average base position 37.17p

The forecast maximum dilution from the New LTIP is 1.6%.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR) AND PERSONS CLOSELY ASSOCIATED WITH THEM

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Trond Williksen

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Benchmark Holdings plc

)

LEI:

2138001UQHM4VZGXUJ19

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1 pence each in the Company

ISIN: GB00BGHPT808

b)

Nature of the transaction:

Options over ordinary shares granted under the Benchmark Holdings PLC Long Term Incentive Plan with an exercise price of 0.1p per share

c)

Price(s) and volume(s):

Type

Price

Volume(s)

Ordinary shares

Nil

1,825,420

Nil

1,216,940

d)

Aggregated information:

· Aggregated volume:

·Price:

Volume: 3,042,360

e)

Date of the transaction:

12 December 2023

f)

Place of the transaction:

Outside of a trading venue

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Septima Maguire

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Benchmark Holdings plc

b)

LEI:

2138001UQHM4VZGXUJ19

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1 pence each in the Company

ISIN: GB00BGHPT808

b)

Nature of the transaction:

Options over ordinary shares granted under the Benchmark Holdings PLC Long Term Incentive Plan with an exercise price of 0.1p per share

c)

Price(s) and volume(s):

Type

Price

Volume(s)

Ordinary shares

Nil

1,244,230

Nil

829,490

d)

Aggregated information:

·Aggregated volume:

·Price:

Volume: 2,073,720

e)

Date of the transaction:

12 December 2023

f)

Place of the transaction:

Outside of a trading venue

Enquiries

Benchmark Holdings plc

Tel: 0114 240 9939

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

?

Deutsche Numis (Broker and NOMAD)

Tel: 020 7260 1000

Freddie Barnfield, Duncan Monteith, Sher Shah

MHP

Tel: 020 3128 8004

Katie Hunt, Reg Hoare

benchmark@mhpgroup.com

About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability. We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFSDFELFLIV
Date   Source Headline
30th May 202311:55 amRNSHolding(s) in Company
23rd May 20237:00 amRNSSecond Quarter and Interim results
5th May 20237:00 amRNSNotice of Q2 and Interim Results
28th Apr 20237:00 amRNSTotal Voting Rights
21st Apr 20231:00 pmRNSDirector Share Options
17th Apr 20237:00 amRNSDirectorate Change
12th Apr 20237:00 amRNSListing of Green NOK Bond
31st Mar 20237:00 amRNSTotal Voting Rights
21st Mar 20235:33 pmRNSShare Premium Reduction
21st Mar 20237:00 amRNSBlock Listing Six Monthly Return
17th Mar 20236:09 pmRNSHolding(s) in Company
2nd Mar 202311:12 amRNSDirector Dealings
28th Feb 20239:00 amRNSTotal Voting Rights
28th Feb 20237:00 amRNSQ1 Results
17th Feb 20237:00 amRNSAcquisition of remaining minority interest
16th Feb 20236:03 pmRNSResult of AGM
14th Feb 202311:45 amRNSNotice of Q1 Results
31st Jan 20237:00 amRNSTotal Voting Rights
27th Jan 20234:40 pmRNSSecond Price Monitoring Extn
27th Jan 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
11th Jan 20238:00 amRNSPosting of Notice of AGM
30th Dec 20227:00 amRNSTotal Voting Rights
16th Dec 20229:58 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSFirst Day of Trading on Euronext Growth Oslo
14th Dec 20229:15 amRNSCompletion of private placement & retail offering
13th Dec 20224:30 pmRNSSufficient number of shares in VPS
6th Dec 20226:21 pmRNSSuccessful private placement and retail offering
6th Dec 20227:00 amRNSLast day of bookbuilding and application period
1st Dec 20223:36 pmRNSPublication of Annual Report and Notice of AGM
1st Dec 202210:58 amRNSStatus of bookbuilding
1st Dec 20227:00 amRNSProspectus & Commencement of Bookbuilding Period
30th Nov 202210:00 amRNSTotal Voting Rights
30th Nov 20227:01 amRNSPrivate Placing & Retail Offering
30th Nov 20227:00 amRNSQ4 Results
30th Nov 20227:00 amRNSFull Year Results
25th Nov 20227:00 amRNSNotice of Results
14th Nov 20224:40 pmRNSSecond Price Monitoring Extn
14th Nov 20224:35 pmRNSPrice Monitoring Extension
14th Nov 20224:35 pmRNSChange of Registered Office
31st Oct 20227:00 amRNSTotal Voting Rights
24th Oct 20227:00 amRNSTrading Update
19th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSTotal Voting Rights
21st Sep 20227:00 amRNSBlock listing Six Monthly Return
20th Sep 20227:00 amRNSBenchmark hosts Capital Markets Day today

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.